# The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye

> **NCT04668118** · PHASE4 · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 68 (estimated)

## Conditions studied

- Dry Eye Syndromes
- Computer Vision Syndrome
- Asthenopia

## Interventions

- **DRUG:** Diquafosol

## Key facts

- **NCT ID:** NCT04668118
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2023-03-25
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04668118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04668118, "The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04668118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*